Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001214659-26-003142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-11 | 2026-03-10 | AQST | Korczynski Sherry | Chief Commercial Off | S - Sale | $4.17 | -15.7K | 241.1K | -6% | -$65.6K |
| D | 2026-03-11 | 2026-03-09 | AQST | Korczynski Sherry | Chief Commercial Off | A - Grant | $0.00 | +75.0K | 256.9K | +41% | $0 |
| D | 2026-03-11 | 2026-03-09 | AQST | Korczynski Sherry | Chief Commercial Off | A - Grant | $4.29 | +42.5K | 42.5K | New | +$182.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | S | D | 15,741 | $4.17 | 241,117 | D | — | — | (F2) Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. (F3) This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-03-09 | A | A | 75,000 | $0.00 | 256,858 | D | — | — | (F1) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-03-09 | A | A | 42,500 | $4.29 | 42,500 | D | $4.29 · — to 2036-03-09 | 42,500 Common Stock | (F4) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |